Pancreatic Cancer Research

ResearcherCornell UniversityNo recent work listed

Sara H. Olson

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-0182-2754; OpenAlex author ID A5055676175; NIH RePORTER profile ID 1872521. Sources: OpenAlex.

Their work

Papers
42 (first author 4, last author 1)
Trials
0
Grants
1
Labs led
1
Collaborators
127
Papers, trials and grants by year

2011: 3 papers · 2012: 6 papers · 2013: 5 papers, 1 grant · 2014: 6 papers · 2015: 4 papers · 2016: 5 papers · 2017: 3 papers · 2018: 3 papers · 2019: 4 papers · 2020: 1 paper · 2021: 2 papers

Papers 42

  1. The p.Ser64Leu and p.Pro104Leu missense variants of PALB2 identified in familial pancreatic cancer patients compromise the DNA damage response. Co-author DOI 10.1002/humu.24133↗
  2. A pooled genome-wide association study identifies pancreatic cancer susceptibility loci on chromosome 19p12 and 19p13.3 in the full-Jewish population. Co-author DOI 10.1007/s00439-020-02205-8↗
  3. Gallbladder disease, cholecystectomy, and pancreatic cancer risk in the International Pancreatic Cancer Case-Control Consortium (PanC4). Co-author DOI 10.1097/cej.0000000000000572↗
  4. Agnostic Pathway/Gene Set Analysis of Genome-Wide Association Data Identifies Associations for Pancreatic Cancer. Co-author DOI 10.1093/jnci/djy155↗
  5. Analysis of Heritability and Genetic Architecture of Pancreatic Cancer: A PanC4 Study. Co-author DOI 10.1158/1055-9965.epi-18-1235↗
  6. Outcome of Pancreatic Cancer Surveillance Among High-Risk Individuals Tested for Germline Mutations in BRCA1 and BRCA2. First author DOI 10.1158/1940-6207.capr-18-0272↗
  7. A region-based gene association study combined with a leave-one-out sensitivity analysis identifies SMG1 as a pancreatic cancer susceptibility gene. Co-author DOI 10.1371/journal.pgen.1008344↗
  8. Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer. Co-author DOI 10.1038/s41467-018-02942-5↗
  9. Mutations in the pancreatic secretory enzymes CPA1 and CPB1 are associated with pancreatic cancer. Co-author DOI 10.1073/pnas.1720588115↗
  10. The Association of Recently Diagnosed Diabetes and Long-term Diabetes With Survival in Pancreatic Cancer Patients: A Pooled Analysis. Last author DOI 10.1097/mpa.0000000000000989↗
  11. The oral microbiota in patients with pancreatic cancer, patients with IPMNs, and controls: a pilot study. Co-author DOI 10.1007/s10552-017-0933-8↗
  12. Impact of Sixteen Established Pancreatic Cancer Susceptibility Loci in American Jews. Co-author DOI 10.1158/1055-9965.epi-17-0262↗
  13. Epidemiology of pancreatic adenocarcinoma. First author DOI 10.21037/cco.2017.06.32↗
  14. Functional characterization of a chr13q22.1 pancreatic cancer risk locus reveals long-range interaction and allele-specific effects on DIS3 expression. Co-author DOI 10.1093/hmg/ddw300↗
  15. Weight Loss, Diabetes, Fatigue, and Depression Preceding Pancreatic Cancer. Co-author DOI 10.1097/mpa.0000000000000590↗
  16. Menstrual and Reproductive Factors, Hormone Use, and Risk of Pancreatic Cancer: Analysis From the International Pancreatic Cancer Case-Control Consortium (PanC… Co-author DOI 10.1097/mpa.0000000000000635↗
  17. Whole Genome Sequencing Defines the Genetic Heterogeneity of Familial Pancreatic Cancer. Co-author DOI 10.1158/2159-8290.cd-15-0402↗
  18. Three new pancreatic cancer susceptibility signals identified on chromosomes 1q32.1, 5p15.33 and 8q24.21. Co-author DOI 10.18632/oncotarget.11041↗
  19. TERT gene harbors multiple variants associated with pancreatic cancer susceptibility. Co-author DOI 10.1002/ijc.29590↗
  20. Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer. Co-author DOI 10.1038/ng.3341↗
  21. Vitamin D metabolic pathway genes and pancreatic cancer risk. Co-author DOI 10.1371/journal.pone.0117574↗
  22. Correction: vitamin d metabolic pathway genes and pancreatic cancer risk. Co-author DOI 10.1371/journal.pone.0129983↗
  23. Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer. Co-author DOI 10.1038/ng.3052↗
  24. Diabetes, antidiabetic medications, and pancreatic cancer risk: an analysis from the International Pancreatic Cancer Case-Control Consortium. Co-author DOI 10.1093/annonc/mdu276↗
  25. Axonal guidance signaling pathway interacting with smoking in modifying the risk of pancreatic cancer: a gene- and pathway-based interaction analysis of GWAS d… Co-author DOI 10.1093/carcin/bgu010↗
  26. Genes-environment interactions in obesity- and diabetes-associated pancreatic cancer: a GWAS data analysis. Co-author DOI 10.1158/1055-9965.epi-13-0437-t↗
  27. Serum immunoglobulin e and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. Co-author DOI 10.1158/1055-9965.epi-13-1359↗
  28. Genome-wide analysis of the role of copy-number variation in pancreatic cancer risk. Co-author DOI 10.3389/fgene.2014.00029↗
  29. Epidemiology of pancreatic cancer and the role of family history. Co-author DOI 10.1002/jso.23149↗
  30. Polymorphisms in genes related to one-carbon metabolism are not related to pancreatic cancer in PanScan and PanC4. Co-author DOI 10.1007/s10552-012-0138-0↗
  31. Allergies and risk of pancreatic cancer: a pooled analysis from the Pancreatic Cancer Case-Control Consortium. Co-author DOI 10.1093/aje/kwt052↗
  32. Ulcer, gastric surgery and pancreatic cancer risk: an analysis from the International Pancreatic Cancer Case-Control Consortium (PanC4). Co-author DOI 10.1093/annonc/mdt336↗
  33. An absolute risk model to identify individuals at elevated risk for pancreatic cancer in the general population. Co-author DOI 10.1371/journal.pone.0072311↗
  34. Selected medical conditions and risk of pancreatic cancer. Co-author DOI 10.1002/mc.20816↗
  35. Cigarette smoking and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (Panc4). Co-author DOI 10.1093/annonc/mdr541↗
  36. Pancreatitis and pancreatic cancer risk: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4). Co-author DOI 10.1093/annonc/mds140↗
  37. Pathway analysis of genome-wide association study data highlights pancreatic development genes as susceptibility factors for pancreatic cancer. Co-author DOI 10.1093/carcin/bgs151↗
  38. A replication study and genome-wide scan of single-nucleotide polymorphisms associated with pancreatic cancer risk and overall survival. First author DOI 10.1158/1078-0432.ccr-11-2856↗
  39. Impact of obesity and body fat distribution on survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Co-author DOI 10.1245/s10434-012-2301-y↗
  40. Feasibility and yield of screening in relatives from familial pancreatic cancer families. First author DOI 10.1038/ajg.2011.65↗
  41. Cigar and pipe smoking, smokeless tobacco use and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (PanC4). Co-author DOI 10.1093/annonc/mdq613↗
  42. Reply to Are cohort data on smokeless tobacco use and pancreatic cancer confounded by alcohol use? Co-author DOI 10.1093/annonc/mdr305↗

Grants 1

  1. Serum IgE and Risk of Pancreatic Cancer U01CA150138↗

Closest collaborators

The 25 strongest of 127 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Robert C. Kurtz · 24 shared papers, 2011–2021 · strength 1.23
  2. Gloria M. Petersen · 14 shared papers, 2011–2020 · strength 0.54
  3. Harvey A. Risch · 11 shared papers, 2011–2021 · strength 0.49
  4. Steve Gallinger · 14 shared papers, 2011–2019 · strength 0.49
  5. Alison P. Klein · 7 shared papers, 2016–2021 · strength 0.48
  6. Paige M. Bracci · 12 shared papers, 2011–2019 · strength 0.37
  7. Carlo La Vecchia · 10 shared papers, 2011–2020 · strength 0.36
  8. H. Bas Bueno-de-Mesquita · 11 shared papers, 2011–2020 · strength 0.35
  9. Eric J. Duell · 11 shared papers, 2011–2020 · strength 0.35
  10. Amethyst Saldia · 4 shared papers, 2016–2019 · strength 0.31
  11. Cristina Bosetti · 7 shared papers, 2011–2020 · strength 0.27
  12. Laufey Thora Amundadottir · 3 shared papers, 2016–2021 · strength 0.26
  13. Patrick Maisonneuve · 8 shared papers, 2011–2020 · strength 0.24
  14. Donghui Li · 4 shared papers, 2014–2019 · strength 0.22
  15. Samantha A. Streicher · 2 shared papers, 2017–2021 · strength 0.22
  16. Paolo Boffetta · 7 shared papers, 2011–2020 · strength 0.22
  17. Herbert Yu · 7 shared papers, 2011–2019 · strength 0.21
  18. Eva Negri · 6 shared papers, 2011–2020 · strength 0.19
  19. Ghislaine Scélo · 3 shared papers, 2014–2020 · strength 0.18
  20. Debra T. Silverman · 7 shared papers, 2011–2014 · strength 0.17
  21. Randall E. Brand · 3 shared papers, 2016–2019 · strength 0.16
  22. Nicholas Jason Roberts · 3 shared papers, 2016–2019 · strength 0.16
  23. Sapna Syngal · 3 shared papers, 2016–2019 · strength 0.16
  24. Elena M. Stoffel · 3 shared papers, 2016–2019 · strength 0.16
  25. George Zogopoulos · 3 shared papers, 2016–2019 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.